Novo Nordisk application for oral Wegovy accepted by USFDA for weight loss Ruchika Sharma3 May 2025 3:21 PM ISTPlainsboro: Novo Nordisk has announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) submission for an...
Novo Nordisk Withdrawal to Reshape Insulin Market; Lupin's Huminsulin to Gain Spotlight Farhat Nasim24 April 2025 6:29 PM ISTMumbai: Amidst the ongoing news of conventional insulin market disruption and growing concern over potential shortages triggered by Novo...
As Ozempic, Wegovy Take Priority, Novo Nordisk Winds Down Insulin Portfolio In India Farhat Nasim22 April 2025 7:04 PM ISTNew Delhi: Danish pharmaceutical giant Novo Nordisk has announced plans to phase out Human Mixtard, India's top-selling insulin brand. This...
Conduct CT in India: CDSCO Panel tells Novo Nordisk India For new formulation of Semaglutide tablets Dr. Divya Colin17 April 2025 5:30 PM ISTNew Delhi: In line with the proposal for approval of Semaglutide tablets 1.5 mg, 4 mg, 9 mg of new formulation based on the bioequivalence (BE)...
Novo Nordisk promotes Rishang Deoras to Global Director - Diabetes Commercial Unit Ruchika Sharma17 April 2025 5:30 PM ISTNovo Nordisk has promoted Rishang Deoras to Global Director - Diabetes Commercial Unit.Deoras shared the news in a LinkedIn post,...
Novo Nordisk reshapes Executive management team Ruchika Sharma4 April 2025 11:30 AM IST Novo Nordisk HA has announced that Camilla Sylvest has decided to leave the company after a distinguished career of 28 years with the Company,...
Novo Nordisk, The United Bio-Technology ink pact for 'triple G' obesity drug Ruchika Sharma25 March 2025 3:30 PM ISTChina: Novo Nordisk and The United Laboratories International Holdings Limited (TUL)'s wholly-owned subsidiary The United Bio-Technology...
Novo Nordisk regains membership in UK pharma body Ruchika Sharma18 March 2025 3:30 PM ISTLondon: Danish pharmaceutical giant Novo Nordisk has regained its membership in the UK's pharmaceutical industry body after serving a two-year...
CagriSema demonstrates superior weight loss in adults with obesity, type 2 diabetes in REDEFINE 2 trial: Novo Nordisk Ruchika Sharma14 March 2025 2:00 PM ISTDenmark: CagriSema has demonstrated superior weight loss in adults with obesity or overweight and type 2 diabetes in the REDEFINE 2 trial, Novo...
Eris Lifesciences ropes in Murari Ranganathan as President, Cardiometabolic Business Ruchika Sharma6 March 2025 12:21 PM ISTMumbai: Eris Lifesciences Limited, a Indian branded formulations manufacturing company, has appointed Murari Ranganathan as President,...
Novo Nordisk Gets CDSCO Panel Nod To Import, Market Concizumab Injection Dr. Divya Colin5 March 2025 6:00 PM ISTNew Delhi: Citing that there is unmet medical need in the country for the proposed indication, the Subject Expert Committee (SEC) functional under the...
Novo Nordisk Gets CDSCO Panel Nod To study CDR132L Dr. Divya Colin23 Feb 2025 6:00 PM ISTNew Delhi: Novo Nordisk has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation...
